To the President of the United States, Prostate Cancer incidence rates are comparable to Breast Cancer rates. Yet, federal funding is significantly higher for Breast Cancer research than for Prostate Cancer. In 2011, there were the same number of new cases of Prostate Cancer (186,320) as Breast Cancer (184,450), as estimated by the American Cancer Society. - In 2010, Breast Cancer received almost two thirds more funding ($127.5 million) from the Congressionally Directed Medical Research Program as did Prostate Cancer ($80 million dollars) (59.5% difference).
- In 2010, Breast Cancer received more than twice as much funding ($707 million) as did Prostate Cancer ($305 million) from our nation’s medical research agency, the National Institutes of Health (231% difference).
Breast and Prostate Cancer scientists should not be made to compete for limited research funding. Scientists must feel encouraged to develop prostate cancer research. Both Breast Cancer and Prostate Cancer research funding must continue to grow. Breast Cancer and Prostate Cancer patients, equal in number, should receive equal and adequate funding and promotion for research. We, the undersigned, call on the President of the United States and the Congress to make Prostate Cancer research a national public health priority. Specifically, we ask the President of the United States to ensure that promotion and funding for Prostate Cancer research is, at all times, comparable to those levels allocated for Breast Cancer. | 
